ProShare Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,367
| Closed | -$636K | – | 2463 |
|
|
2021
Q1 | $636K | Sell |
5,367
-619
| -10% | -$73.2K | ﹤0.01% | 1289 |
|
|
2020
Q4 | $707K | Sell |
5,986
-232
| -4% | -$26.9K | ﹤0.01% | 1056 |
|
|
2020
Q3 | $691K | Buy |
6,218
+68
| +1% | +$7.3K | ﹤0.01% | 825 |
|
|
2020
Q2 | $628K | Buy |
6,150
+850
| +16% | +$91K | ﹤0.01% | 856 |
|
|
2020
Q1 | $572K | Sell |
5,300
-3,031
| -36% | -$348K | ﹤0.01% | 707 |
|
|
2019
Q4 | $970K | Sell |
8,331
-2,027
| -20% | -$235K | ﹤0.01% | 804 |
|
|
2019
Q3 | $1.19M | Sell |
10,358
-1,007
| -9% | -$100K | 0.01% | 708 |
|
|
2019
Q2 | $1.08M | Sell |
11,365
-2,007
| -15% | -$189K | 0.01% | 733 |
|
|
2019
Q1 | $1.22M | Buy |
13,372
+32
| +0.2% | +$2.62K | 0.01% | 708 |
|
|
2018
Q4 | $1.01M | Sell |
13,340
-1,857
| -12% | -$137K | 0.01% | 700 |
|
|
2018
Q3 | $1.22M | Buy |
15,197
+1,272
| +9% | +$119K | 0.01% | 741 |
|
|
2018
Q2 | $1.38M | Buy |
13,925
+1,160
| +9% | +$100K | 0.01% | 720 |
|
|
2018
Q1 | $1.03M | Sell |
12,765
-2,110
| -14% | -$171K | 0.01% | 805 |
|
|
2017
Q4 | $1.17M | Sell |
14,875
-466
| -3% | -$38.7K | 0.01% | 772 |
|
|
2017
Q3 | $1.42M | Buy |
15,341
+1,380
| +10% | +$133K | 0.01% | 645 |
|
|
2017
Q2 | $1.58M | Sell |
13,961
-549
| -4% | -$61.4K | 0.02% | 615 |
|
|
2017
Q1 | $1.45M | Sell |
14,510
-3,419
| -19% | -$365K | 0.02% | 647 |
|
|
2016
Q4 | $1.93M | Buy |
17,929
+617
| +4% | +$72.1K | 0.02% | 561 |
|
|
2016
Q3 | $2.15M | Sell |
17,312
-2,481
| -13% | -$293K | 0.03% | 465 |
|
|
2016
Q2 | $2.1M | Buy |
19,793
+109
| +0.6% | +$12.7K | 0.03% | 493 |
|
|
2016
Q1 | $2.25M | Sell |
19,684
-1,652
| -8% | -$194K | 0.03% | 423 |
|
|
2015
Q4 | $3.04M | Buy |
+21,336
| New | +$2.46M | 0.04% | 390 |
|
ProShare Advisors's CBPO Position: Q2 2021 in Review
ProShare Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 5,367 shares — an estimated $636K sold.
ProShare Advisors first reported a position in CBPO in Q4 2015 and held it in 22 quarters. The position peaked at $3.04M in Q4 2015. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- ProShare Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- ProShare Advisors sold 5,367 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $636K.
- ProShare Advisors first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 22 quarters.
- ProShare Advisors's China Biologic Products Holdings, Inc. position peaked at $3.04M in Q4 2015.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.